National Bank of Canada
GILD icon

National Bank of Canada’s Gilead Sciences GILD Stock Holding History

National Bank of Canada’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,000
Closed -$24.7M – 2756
2022
Q2 		$24.7M Buy
+4,000
New +$248K 0.11% 204

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

National Bank of Canada's GILD Position: Q2 2026 in Review

National Bank of Canada increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $43.8M and bringing the position to 1,946,858 shares worth $246M. The position accounts for 0.18% of the portfolio, ranked #105.

National Bank of Canada first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. 1,509 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • National Bank of Canada held 1,946,858 shares of Gilead Sciences worth $246M as of Q2 2026.
  • National Bank of Canada bought 332,358 Gilead Sciences shares in Q2 2026, an estimated $43.8M.
  • Gilead Sciences made up 0.18% of National Bank of Canada's portfolio in Q2 2026, its #105 holding.
  • National Bank of Canada first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • 1,509 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.